[Induction of canine gastric and esophageal cancers by N-ethyl-N'-nitro-N-nitrosoguanidine (ENNG)].
Hasegawa
H
H
D000230:Adenocarcinoma / Q000139:chemically induced* / Q000473:pathology; D000818:Animals; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced* / Q000473:pathology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004938:Esophageal Neoplasms / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D008769:Methylnitronitrosoguanidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D013274:Stomach Neoplasms / Q000139:chemically induced* / Q000473:pathology
D008769:Methylnitronitrosoguanidine; C013525:ENNG